These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18212081)

  • 21. Dynamics of the antibody response to Plasmodium falciparum infection in African children.
    White MT; Griffin JT; Akpogheneta O; Conway DJ; Koram KA; Riley EM; Ghani AC
    J Infect Dis; 2014 Oct; 210(7):1115-22. PubMed ID: 24719471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania.
    Vestergaard LS; Lusingu JP; Nielsen MA; Mmbando BP; Dodoo D; Akanmori BD; Alifrangis M; Bygbjerg IC; Lemnge MM; Staalsoe T; Hviid L; Theander TG
    Infect Immun; 2008 Jun; 76(6):2706-14. PubMed ID: 18250179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa.
    Nebie I; Diarra A; Ouedraogo A; Soulama I; Bougouma EC; Tiono AB; Konate AT; Chilengi R; Theisen M; Dodoo D; Remarque E; Bosomprah S; Milligan P; Sirima SB
    Infect Immun; 2008 Feb; 76(2):759-66. PubMed ID: 18070896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
    Tonhosolo R; Wunderlich G; Ferreira MU
    J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody responses to Rhoptry-Associated Protein-1 (RAP-1) of Plasmodium falciparum parasites in humans from areas of different malaria endemicity.
    Jakobsen PH; Kurtzhals JA; Riley EM; Hviid L; Theander TG; Morris-Jones S; Jensen JB; Bayoumi RA; Ridley RG; Greenwood BM
    Parasite Immunol; 1997 Sep; 19(9):387-93. PubMed ID: 9347514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission.
    Nogaro SI; Hafalla JC; Walther B; Remarque EJ; Tetteh KK; Conway DJ; Riley EM; Walther M
    PLoS One; 2011; 6(10):e25582. PubMed ID: 21991321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of host humoral antibody production against Plasmodium falciparum recombinant circumsporozoite antigen in Nigerian children.
    Oluwasogo OA; Ebenezer OO; Chiaka A
    J Vector Borne Dis; 2012 Sep; 49(3):151-6. PubMed ID: 23135009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
    Roussilhon C; Oeuvray C; Müller-Graf C; Tall A; Rogier C; Trape JF; Theisen M; Balde A; Pérignon JL; Druilhe P
    PLoS Med; 2007 Nov; 4(11):e320. PubMed ID: 18001147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of antibody responses to Plasmodium falciparum antigens in individuals differentially exposed to Anopheles bites.
    Aka KG; Traoré DF; Sagna AB; Zoh DD; Assi SB; Tchiekoi BN; Adja AM; Remoue F; Poinsignon A
    Malar J; 2020 Feb; 19(1):83. PubMed ID: 32085710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquisition and decay of IgM and IgG responses to merozoite antigens after Plasmodium falciparum malaria in Ghanaian children.
    Walker MR; Knudsen AS; Partey FD; Bassi MR; Frank AM; Castberg FC; Sarbah EW; Ofori MF; Hviid L; Barfod L
    PLoS One; 2020; 15(12):e0243943. PubMed ID: 33332459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana.
    Kusi KA; Manu EA; Manful Gwira T; Kyei-Baafour E; Dickson EK; Amponsah JA; Remarque EJ; Faber BW; Kocken CHM; Dodoo D; Gyan BA; Awandare GA; Atuguba F; Oduro AR; Koram KA
    PLoS One; 2017; 12(9):e0185303. PubMed ID: 28945794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.
    Torres KJ; Clark EH; Hernandez JN; Soto-Cornejo KE; Gamboa D; Branch OH
    Malar J; 2008 Sep; 7():173. PubMed ID: 18782451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between circulating S-antigens, naturally acquired antibodies to Plasmodium falciparum exoantigens and malaria attack in a mesoendemic area.
    Chumpitazi BF; Peyron F; Boudin C; Picot S; Oury B; Ambroise-Thomas P
    Acta Trop; 1992 Apr; 50(4):295-304. PubMed ID: 1356300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.
    Ahmed Ismail H; Tijani MK; Langer C; Reiling L; White MT; Beeson JG; Wahlgren M; Nwuba R; Persson KE
    Malar J; 2014 Nov; 13():425. PubMed ID: 25373511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgM in human immunity to
    Boyle MJ; Chan JA; Handayuni I; Reiling L; Feng G; Hilton A; Kurtovic L; Oyong D; Piera KA; Barber BE; William T; Eisen DP; Minigo G; Langer C; Drew DR; de Labastida Rivera F; Amante FH; Williams TN; Kinyanjui S; Marsh K; Doolan DL; Engwerda C; Fowkes FJI; Grigg MJ; Mueller I; McCarthy JS; Anstey NM; Beeson JG
    Sci Adv; 2019 Sep; 5(9):eaax4489. PubMed ID: 31579826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody responses to a C-terminal fragment of the Plasmodium falciparum blood-stage antigen Pf332 in Senegalese individuals naturally primed to the parasite.
    Israelsson E; Balogun H; Vasconcelos NM; Beser J; Roussilhon C; Rogier C; Trape JF; Berzins K
    Clin Exp Immunol; 2008 Apr; 152(1):64-71. PubMed ID: 18279441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Specific antibodies to Plasmodium falciparum antigens in immune patients: IV--Cross-sectional analysis of anti-P. falciparum Ab responses in a mesoendemic zone of transmission in Sine-Saloum region].
    Sidibé S; Diouf B; Tall A; Spiegel A; Trape JF; Garraud O; Dièye A; Perraut P
    Dakar Med; 2000; 45(2):117-21. PubMed ID: 15779164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes.
    Mbengue B; Fall MM; Varela ML; Loucoubar C; Joos C; Fall B; Niang MS; Niang B; Mbow M; Dieye A; Perraut R
    Clin Exp Immunol; 2019 Apr; 196(1):86-96. PubMed ID: 30580455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.